Simmons & Simmons advised Eisai on the divestment. Eisai S.A.S, the French subsidiary of Eisai Co., Ltd., has transferred its rights to Loxapac (loxapine) and Parkinane...
CNX Therapeutics’ €56.5m Acquisition of Eisai’s Rights in Loxapac and Parkinane
Helia Renovables III’s Acquisition of Two Onshore Wind Farms in Southern Spain
Watson Farley & Williams advised RIVE Private Investment on the sale, while Plenium Partners and Bankinter Investment were advised by a team from Spanish law firm...
Tenergie and Banque des Territoires’ Launch of Terres d’Energie Développement Platform
Watson Farley & Williams advised Terres d’Energie Développement on the creation of a platform for the development of renewable energy projects serving local communities. Renewable energy...
RGREEN INVEST’s Investment of EUR 250 Million in Econergy
Watson Farley & Williams advised RGREEN INVEST. The cabinet Vlasceanu, Nyerges & Partners and the cabinet Christodoulos G -Vassiliades & Co LLC also assisted RGREEN INVEST...